石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

未开盘 02-02 16:08:06

9.150

-0.450

-4.69%

最高10.100	最低9.120	成交量2.79亿
今开9.700	昨收9.600	日振幅10.21%
总市值1,054亿	流通市值1,054亿	总股本115.22亿
成交额26.36亿	换手率2.42%	流通股本115.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":9.15,"timestamp":1770019686002,"preClose":9.6,"halted":0,"volume":279300702,"delay":0,"changeRate":-0.04687499999999993,"floatShares":11522000000,"shares":11522000000,"eps":0.4148761420315209,"marketStatus":"未开盘","change":-0.45,"latestTime":"02-02 16:08:06","open":9.7,"high":10.1,"low":9.12,"amount":2635872593,"amplitude":0.102083,"askPrice":9.16,"askSize":150000,"bidPrice":9.15,"bidSize":258000,"shortable":3,"etf":0,"ttmEps":0.39859133249246337,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":9.6,"dividendRate":0.026208,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":1.2770390144693273,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1772035200000,"strike":"12.00","timestamp":1770015930269,"price":0.02,"volume":800,"amount":32000,"type":"*"},{"symbol":"CSP.HK","call":true,"expireDate":1772035200000,"strike":"12.00","timestamp":1770010402099,"price":0.03,"volume":431,"amount":25860,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4157,"impliedVolPercentile":0.1767},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2608865380","title":"石药集团(01093)：氯维地平乳状注射液获药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2608865380","media":"智通财经","labels":["productRelease"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608865380?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:42","pubTimestamp":1770032533,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的氯维地平乳状注射液已获得中国国家药品监督管理局颁发的药品注册批件。该产品是二氢吡啶类钙通道阻滞拮抗剂，属于速效静脉降压药，适用于治疗不适宜口服或预期口服药物治疗效果不佳的高血压患者。该产品的获批将进一步丰富集团在心脑血管疾病治疗领域的产品管线，提升集团在该领域的竞争力，并有望填补高血压急症用药的临床需求空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：氯维地平乳状注射液获药品注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","LU1226288170.HKD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU2039709279.SGD","LU1152091168.USD","LU0501845795.SGD","LU0880133367.SGD","LU0072913022.USD","LU1226287875.USD","BK1521","HK0000165453.HKD","LU0067412154.USD","IE0008369823.USD","BK1515","LU0314109678.HKD","LU0315179316.USD","IE00B5MMRT66.SGD","LU0140636845.USD","SG9999004220.SGD","BK1191","LU1328277881.USD","LU0326950275.SGD","LU1960683339.HKD","01093","LU1993786604.SGD","LU1152091754.HKD","LU1951186391.HKD","LU1226288253.USD","IE0008368742.USD","LU1807302812.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2608830853","title":"美银证券：升石药集团(01093)目标价至9.1港元 重申“跑输大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2608830853","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608830853?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:05","pubTimestamp":1770015943,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美银证券发布研报称，将石药集团目标价由8.5港元上调至9.1港元，但重申“跑输大市”评级，因认为集团现有产品组合面临销售压力，且研发管线短期贡献有限，大多数关键资产仍处于早期阶段。报告指，石药集团与阿斯利康合作达成协议，开发创新长效多肽药物，协议总价值最高可达185亿美元。该行指，石药集团于去年5月公布将有3项潜在对外授权交易，是次协议应为第二项落实的交易，而落实时间较预期延迟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","01093"],"gpt_icon":0},{"id":"2608836458","title":"招商证券国际：重申石药集团(01093)“中性”评级 中国创新药进入全球管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2608836458","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608836458?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:50","pubTimestamp":1770000610,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招商证券国际发布研报称，石药集团与阿斯利康达成历史性交易公告，表示看好交易，但需等待石药或阿斯利康披露更多长效GLP-1全球开发细节。重申“中性”评级，认为短期基本面仍存隐忧。该行表示，根据石药最新公告，与阿斯利康合作的关键临床候选药物为SYH2082，长效GLP-1R/GIPR双激动剂，现已进入I期临床。该行认为siRNA进入肥胖维持市场，将对所有胜肽类方案构成真正威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","06099","06978","01093"],"gpt_icon":0},{"id":"2608835381","title":"港股石药集团(01093.HK)早盘涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608835381","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608835381?lang=zh_cn&edition=full","pubTime":"2026-02-02 09:59","pubTimestamp":1769997544,"startTime":"0","endTime":"0","summary":"每经AI快讯，石药集团(01093.HK)早盘涨超5%，截至发稿，涨2.19%，报9.81港元，成交4.46亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602023638288537.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602023638288537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01093","BK1521","BK1191","LU1960683339.HKD","LU1807302812.USD","LU2039709279.SGD","IE00B543WZ88.USD","BK4585","SG9999004220.SGD","LU1226288170.HKD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","IE0008369823.USD","LU0067412154.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU0140636845.USD","LU0326950275.SGD","BK4588","HK0000165453.HKD","IE0008368742.USD","LU0072913022.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","VT","LU1226287792.SGD","LU1152091168.USD","LU1226287875.USD","LU0314109678.HKD","LU1226287529.USD","LU1152091754.HKD","LU0880133367.SGD","BK1515","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2608833532","title":"中金：石药集团(01093)与阿斯利康达成重磅合作 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2608833532","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608833532?lang=zh_cn&edition=full","pubTime":"2026-02-02 09:37","pubTimestamp":1769996220,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持石药集团“跑赢行业”评级，考虑对外授权持续兑现上调目标价9.1%到12港元。石药集团公告与阿斯利康签订研发合作与授权协议。中金主要观点如下：中国创新药授权出海再获里程碑式突破根据公告，石药集团及附属公司授权阿斯利康在全球范围内独家开发、生产和商业化8个创新长效多肽药物项目，阿斯利康将支付合计12亿美元预付款以及后续累计最高35亿/138亿美元的开发/销售里程碑款项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","AZN"],"gpt_icon":0},{"id":"2608405007","title":"签下185亿美元超级大单，石药为何反遭抛售？“聪明钱”悄然借道港股通创新药ETF（520880）埋伏","url":"https://stock-news.laohu8.com/highlight/detail?id=2608405007","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608405007?lang=zh_cn&edition=full","pubTime":"2026-02-01 19:37","pubTimestamp":1769945820,"startTime":"0","endTime":"0","summary":"中国创新药出海BD再获里程碑式突破！　　1月30日，石药集团宣布已与全球生物制药领导者阿斯利康签订战略研发合作与授权协议，以利用集团专有的缓释给药技术平台及多肽药物AI发现平台，开发创新长效多肽药物。若后续所有研发及销售里程碑均达成，石药集团方面有权获得总计高达185亿美元的款项。其12亿美元的预付款，仅次于此前三生制药与辉瑞就PD-1/VEGF达成的数额。此前10日，520880累获逾2.74亿元资金净申购。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-02-01/doc-inhkihyz4934390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1008478684.HKD","520880","LU0501845795.SGD","LU1807302812.USD","BK1191","HK0000165453.HKD","LU1813983027.USD","IE0008369823.USD","LU1951186391.HKD","LU1226287792.SGD","LU0880133367.SGD","BK1521","LU0072913022.USD","LU0314109678.HKD","LU0140636845.USD","LU0315179316.USD","IE0008368742.USD","LU2039709279.SGD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","01093","LU1226287875.USD","IE00B031HY20.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287529.USD","SG9999004220.SGD","LU1226288253.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0067412154.USD"],"gpt_icon":0},{"id":"2608045005","title":"$2300亿交易总额太惊人！国产1类新药喜讯不断，石药、恒瑞、海思科......大放异彩","url":"https://stock-news.laohu8.com/highlight/detail?id=2608045005","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608045005?lang=zh_cn&edition=full","pubTime":"2026-02-01 08:33","pubTimestamp":1769906026,"startTime":"0","endTime":"0","summary":"本周，先声与勃林格殷格翰、石药与阿斯利康先后达成授权交易，合作总额分别超12亿美元和185亿美元。近三年“豪夺”$2300亿！2025年1月和10月，信达生物先后达成了两项重磅License-out交易，合计总金额接近125亿美元，涉及4款1类创新药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201095832a46e0f50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260201095832a46e0f50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","BK1515","LU0501845795.SGD","LU0880133367.SGD","LU2039709279.SGD","LU0315179316.USD","LU1008478684.HKD","LU1226287875.USD","IE00B031HY20.USD","LU1226287529.USD","HK0000165453.HKD","LU1993786604.SGD","IE00BZ08YT58.USD","SG9999004220.SGD","01093","IE0008369823.USD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","LU1226288170.HKD","LU1951186391.HKD","IE0008368742.USD","LU0326950275.SGD","LU0072913022.USD","LU1813983027.USD","LU0314109678.HKD","LU1328277881.USD","BK1191","LU1960683339.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","LU1807302812.USD","IE00B543WZ88.USD","LU1226287792.SGD","LU0067412154.USD","LU0140636845.USD"],"gpt_icon":0},{"id":"2608005041","title":"90后！石药创新新任总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2608005041","media":"医药之梯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608005041?lang=zh_cn&edition=full","pubTime":"2026-02-01 07:31","pubTimestamp":1769902268,"startTime":"0","endTime":"0","summary":"石药创新制药于2026年1月30日公告，聘任戴龙先生为公司总经理，聘任徐雯女士为公司董事会秘书及证券事务代表，任期均自董事会审议通过之日起至第六届董事会届满之日止。根据石药创新发布的2025年年度业绩预告。自2024年取得了巨石生物的控制权后，石药创新研发费用就开始大幅增长。2022年、2023和2024年，石药创新研发费用分别为6.66亿元、6.71亿元和8.43亿元，占营收比重分别为23.5%、26.4%和42.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020107332897a44b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020107332897a44b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU1226287529.USD","BK1515","LU1993786604.SGD","LU1152091754.HKD","LU0501845795.SGD","LU0067412154.USD","LU0880133367.SGD","LU0314109678.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU0140636845.USD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1226288253.USD","BK1191","IE0008368742.USD","IE00B031HY20.USD","LU1008478684.HKD","01093","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1813983027.USD","BK1521","IE00BZ08YT58.USD","LU0326950275.SGD","LU1960683339.HKD","LU2039709279.SGD","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2608000504","title":"中英经贸合作新范本：阿斯利康千亿投资引领跨国药企在华发展步伐","url":"https://stock-news.laohu8.com/highlight/detail?id=2608000504","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608000504?lang=zh_cn&edition=full","pubTime":"2026-01-31 18:12","pubTimestamp":1769854377,"startTime":"0","endTime":"0","summary":"2026年1月29日，北京寒意未消，却迎来一场暖意融融的产业盛事——阿斯利康宣布，计划于2030年前在中国投资逾1000亿元人民币，以扩大在药品生产与研发领域的布局。这是阿斯利康自1993年入华33年来最大规模的战略投资。这一数字不仅刷新了跨国药企在华单笔投资纪录，更以全产业链覆盖的深度与广度，成为跨国药企在华战略布局和中国医药产业开放与创新的生动注脚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131181357a6c33f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131181357a6c33f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","IE00BZ08YS42.EUR","06978","LU1226288170.HKD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU2039709279.SGD","LU1152091168.USD","LU0501845795.SGD","LU0880133367.SGD","LU0072913022.USD","LU1226287875.USD","BK1521","HK0000165453.HKD","LU0067412154.USD","IE0008369823.USD","BK1515","IE00B5MMRT66.SGD","LU0140636845.USD","LU0314109678.HKD","LU0315179316.USD","SG9999004220.SGD","BK1191","LU1328277881.USD","LU0326950275.SGD","LU1960683339.HKD","01093","LU1993786604.SGD","BK1574","LU1152091754.HKD","LU1951186391.HKD","LU1226288253.USD","IE0008368742.USD","LU1807302812.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2608005043","title":"阿斯利康与石药集团达成12亿美元的肥胖症治疗资产交易伙伴关系AstraZeneca Partners with CSPC Pharmaceutical in $1.2 Billion Deal for Obesity Treatment Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2608005043","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608005043?lang=zh_cn&edition=full","pubTime":"2026-01-31 16:09","pubTimestamp":1769846940,"startTime":"0","endTime":"0","summary":"by GOAI由GOAI生成Share To分享到AstraZeneca has entered into a significant partnership with CSPC Pharmaceutical Group, agreeing to an upfront payment of $1.2 billion. The deal grants AstraZeneca access to eight assets, including a once-monthly GLP-1 receptor/GIP agonist and long-acting technology aimed at enhancing its portfolio in the obesity treatment market.阿斯利康与石药集团达成了一项重要合作，同意支付12亿美元的预付款。其中关键组成部分之一是一种长效药物递送技术，这项技术可能会在阿斯利康的产品线中提供差异化优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131161316a6c2ff97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131161316a6c2ff97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0072913022.USD","HK0000165453.HKD","LU0067412154.USD","LU0326950275.SGD","LU1328277881.USD","LU0880133367.SGD","LU1226287529.USD","LU0501845795.SGD","LU1807302812.USD","IE00B543WZ88.USD","LU2039709279.SGD","01093","LU1951186391.HKD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1993786604.SGD","IE0008368742.USD","LU1813983027.USD","SG9999004220.SGD","LU1226288170.HKD","IE00BZ08YT58.USD","LU1152091754.HKD","LU1008478684.HKD","LU1226288253.USD","IE00BZ08YS42.EUR","BK1521","LU1226287875.USD","IE00B5MMRT66.SGD","LU0315179316.USD","BK1191","BK1515","LU1152091168.USD","LU0140636845.USD","IE00B031HY20.USD","LU1960683339.HKD","LU0314109678.HKD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2607073008","title":"Tides 周递 | 全球多肽和寡核苷酸药物一周要闻（1.22-1.30）","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073008","media":"多肽圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607073008?lang=zh_cn&edition=full","pubTime":"2026-01-31 09:00","pubTimestamp":1769821223,"startTime":"0","endTime":"0","summary":"Brenipatide 是一款 GLP1R/GIPR 双激动剂，也是继替尔泊肽后，礼来第二款 GLP-1/GIP 双靶点新药。替尔泊肽 2025 年前三季度大卖了 248 亿美元，同比增长 125%。2023年12月，罗氏出手31亿美元收购Carmot Therapeutics，获得了该公司旗下的多款肠促胰岛素药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131091614a6c20546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131091614a6c20546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU1226287529.USD","LU1328277881.USD","BK1191","LU0326950275.SGD","IE00B543WZ88.USD","LU2039709279.SGD","LU1960683339.HKD","IE00BZ08YT58.USD","LU1152091754.HKD","LU0067412154.USD","LU1226288253.USD","LU1226287792.SGD","01093","LU0501845795.SGD","LU0072913022.USD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","IE0008368742.USD","LU0315179316.USD","06938","BK1515","LU1226288170.HKD","LU0314109678.HKD","IE00B031HY20.USD","BK1521","IE0008369823.USD","IE00BZ08YR35.GBP","01276","LU0880133367.SGD","LU1807302812.USD","LU1951186391.HKD","LU1813983027.USD","LU0140636845.USD","LU1226287875.USD","LU1152091168.USD","SG9999004220.SGD","LU1993786604.SGD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2607730740","title":"石药创新“换帅”！90后总经理上任！","url":"https://stock-news.laohu8.com/highlight/detail?id=2607730740","media":"化工邦","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607730740?lang=zh_cn&edition=full","pubTime":"2026-01-31 08:31","pubTimestamp":1769819485,"startTime":"0","endTime":"0","summary":"▌化工邦，医化行业人脉社交和一站式服务平台2026年1月30日，石药创新制药股份有限公司发布重磅公告，宣布公司总经理、董事会秘书及证券事务代表职务发生变更。公告显示，姚兵因工作调动原因申请辞去公司总经理职务，辞职报告自送达董事会时生效，辞去总经理职务后，姚兵仍继续担任公司第六届董事会董事长等职务。公司董事会同意聘任戴龙担任公司总经理，任期自董事会审议通过之日起至第六届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131084936a6c1f406&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131084936a6c1f406&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU1226287529.USD","BK1515","LU1993786604.SGD","LU1152091754.HKD","LU0501845795.SGD","LU0067412154.USD","LU0880133367.SGD","LU0314109678.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU0140636845.USD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1226288253.USD","BK1191","IE0008368742.USD","IE00B031HY20.USD","LU1008478684.HKD","01093","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1813983027.USD","BK1521","IE00BZ08YT58.USD","LU0326950275.SGD","LU1960683339.HKD","LU2039709279.SGD","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2607073072","title":"英国阿斯利康牵头中国药企布局减肥市场，潜在交易额185亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073072","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607073072?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:17","pubTimestamp":1769782620,"startTime":"0","endTime":"0","summary":"英国阿斯利康30日宣布与中国石药集团达成最高价值185亿美元授权协议，合作开发减肥与糖尿病药物。阿斯利康将获石药集团每月一次注射用体重管理产品全球独家开发、生产与商业化权利（中国大陆、港澳台地区除外），双方还将就四个新增项目合作，石药集团保留相关产品在中国内地、港澳台地区的全部权益。财务上，石药集团将获12亿美元预付款及最高173亿美元里程碑付款和销售提成。若目标达成，该交易总价值或超近期多笔重磅肥胖症药物交易。协议将为阿斯利康肥胖症药物研发提供支撑，助其在市场中竞争。阿斯利康执行副总裁称，此次合作将推动体重管理产品线发展，有望带来革命性突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223021a469b15a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223021a469b15a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU0501845795.SGD","IE00BZ08YS42.EUR","LU0880133367.SGD","LU1328277881.USD","LU1226287875.USD","LU0072913022.USD","LU1226287529.USD","HK0000165453.HKD","BK1515","BK1521","LU0315179316.USD","IE00B031HY20.USD","LU1226287792.SGD","LU0140636845.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU2039709279.SGD","LU0067412154.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","IE0008368742.USD","01093","LU1807302812.USD","LU1008478684.HKD","LU1152091168.USD","IE0008369823.USD","BK1191","IE00B543WZ88.USD","LU1226288170.HKD","LU1951186391.HKD","LU0326950275.SGD","LU1152091754.HKD","LU1960683339.HKD","LU1813983027.USD"],"gpt_icon":0},{"id":"2607077073","title":"阿斯利康全球CEO：拟未来五年在华投资千亿 竞逐下一代疗法发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2607077073","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607077073?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:34","pubTimestamp":1769772840,"startTime":"0","endTime":"0","summary":"1月30日，阿斯利康CEO苏博科在接受媒体采访时表示，在英国首相斯塔默访华期间公布对华投资的消息意义重大。这也是阿斯利康史上最大规模对华投资计划。截至去年年底，阿斯利康累计对华投资已经超过50亿美元。阿斯利康表示，新的投资计划将增强公司在细胞疗法和放射性配体疗法等前沿技术方面的能力，中国在这些领域的领先地位已得到公认。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130193645a4691a07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130193645a4691a07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU1960683339.HKD","LU1226288170.HKD","BK1191","LU0501845795.SGD","LU1813983027.USD","LU0880133367.SGD","LU1226288253.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1226287792.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1951186391.HKD","LU1993786604.SGD","01093","BK1521","IE0008368742.USD","LU0314109678.HKD","LU0067412154.USD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU0315179316.USD","BK1515","LU1807302812.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287529.USD","IE00BZ08YR35.GBP","LU1328277881.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2607129630","title":"185亿美元！石药集团创纪录BD落地，股价反跌10%，什么情况？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607129630","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607129630?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:30","pubTimestamp":1769772600,"startTime":"0","endTime":"0","summary":"中国创新药出海BD再获里程碑式突破！若后续所有研发及销售里程碑均达成，石药集团方面有权获得总计高达185亿美元的款项。　　不过，二级市场反应不佳，石药集团股价高开低走，盘中一度狂泻近13%，收跌10.2%。　　从石药集团股价近日表现来看，市场可能提前定价。在此次协议公告前，石药集团已连续多日强势上涨，尤其在1月28日，股价单日大涨6.14%创年内新高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-01-30/doc-inhkauvc6907931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0326950275.SGD","BK1515","LU1993786604.SGD","IE00B031HY20.USD","LU1226288170.HKD","BK1191","LU1328277881.USD","LU0315179316.USD","LU0140636845.USD","LU1226287529.USD","IE0008369823.USD","LU0501845795.SGD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1807302812.USD","LU0067412154.USD","LU0314109678.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","01093","LU1813983027.USD","LU1152091754.HKD","LU1960683339.HKD","HK0000165453.HKD","SG9999004220.SGD","LU1226287792.SGD","LU0880133367.SGD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1152091168.USD","BK1521","LU1008478684.HKD","LU2039709279.SGD","IE00B543WZ88.USD","LU1226288253.USD","LU1226287875.USD"],"gpt_icon":0},{"id":"2607160350","title":"图解丨南下资金净买入石药集团、小米，净卖出紫金矿业、中国移动","url":"https://stock-news.laohu8.com/highlight/detail?id=2607160350","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607160350?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:04","pubTimestamp":1769767491,"startTime":"0","endTime":"0","summary":"格隆汇1月30日｜南下资金今日净买入港股32.22亿港元。其中： 净买入石药集团9.34亿、小米集团-W 9.14亿、盈富基金5.89亿、阿里巴巴-W 3.29亿、长飞光纤光缆2.41亿； 净卖出紫金矿业6.35亿、中国移动5.41亿、中国海洋石油5.25亿、腾讯控股2.13亿、山东黄金2.06亿。 据统计，南下资金已连续20日净卖出中国移动，共计159.752亿港元；连续5日净卖出紫金矿业，共计37.8638亿港元；连续5日净卖出中芯国际，共计12.2751亿港元。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130181006a6bfb736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130181006a6bfb736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0540923850.HKD","HK0000352382.USD","LU0823413660.USD","LU0650527681.SGD","LU0072913022.USD","LU1522347837.USD","LU0329678337.USD","BK1594","BK1615","LU0345775950.USD","LU0417516738.SGD","LU1251922891.USD","LU1770034418.SGD","LU2087589342.USD","IE00B5MMRT66.SGD","LU1880383440.USD","LU0634319403.HKD","LU0314109678.HKD","LU0594300179.USD","BK1544","LU1634259557.SGD","LU2476274720.SGD","LU0307460666.USD","LU0143863198.USD","LU0329678170.USD","LU1152091754.HKD","LU0106252389.USD","LU0359201885.HKD","LU0918141887.USD","IE00B543WZ88.USD","LU1831875114.USD","LU0449509016.USD","LU0326950275.SGD","LU2097828474.EUR","LU1048596156.SGD","01093","BK1589","LU0210526637.USD","LU0499858602.USD","LU0588546209.SGD","LU0880133367.SGD","LU1242518857.USD","LU0449515922.USD","LU0593848301.USD","LU1769817096.USD","LU2226246903.HKD","HK0000306701.USD","LU0823413587.USD","LU1224709979.USD","HK0000252152.HKD","LU0327786744.USD","LU0315179316.USD","LU1152091168.USD","LU0823397285.USD","LU0169518387.USD","LU0067412154.USD","LU2476274308.USD","LU0231483743.USD","LU0039217434.USD","LU0348814723.USD","LU1961090484.USD","BK1521","LU1323998911.USD","LU0417516902.SGD","LU0348816934.USD","BK1592","02899","SG9999004220.SGD","LU0611395673.USD","LU2543165471.USD","601899","LU0456846285.SGD","SG9999002463.SGD","HK0000352291.HKD","LU1481107354.HKD","LU2148510915.USD","IE0032431581.USD","HSI","MIUmain","00941","LU1769817179.HKD","LU0823040885.USD","LU0828237510.HKD","LU0061477393.USD","LU0737861699.HKD","HXXD.SI","LU0828237940.HKD","LU1794554557.SGD","IE0008368742.USD","LU0181495838.USD","LU1105468828.SGD","LU1504937902.USD","LU1242518931.SGD","LU0117841782.USD","LU1993786604.SGD","BK1193","LU1023057109.AUD","00883","601869","LU0143863784.USD","BK1515","LU0700851271.USD","LU0096374516.USD","LU0823426308.USD","LU0871576103.HKD","LU0235996351.USD","LU1226287792.SGD","IE00BZ08YT58.USD","ZIJMY","LU0345776255.USD","02800","SG9999001093.SGD","LU0287142896.SGD","LU0164865239.USD","LU0605514214.HKD","BK1575","HK0000165453.HKD","LU0675040207.SGD","LU1064131003.USD","LU0463099449.HKD","LU0594300419.USD","BK1523","LU0049853897.USD","LU1282648689.USD","01810","LU1226288170.HKD","LU1956131251.USD","BK1198","IE00B031HY20.USD","LU1960683339.HKD","LU0345780281.USD","LU0797268264.HKD","IE0008369823.USD","LU0266512127.USD","LU0228659784.USD","LU2399975544.HKD","LU0821914370.USD","XIACY","BK1607","LU0348825331.USD","LU2778985437.USD","LU0499858438.USD","600941","LU1770036033.HKD","IE00B3M56506.USD","LU0345780521.USD","LU0173614495.USD","SG9999003461.SGD","BK1610","LU0254981946.USD","LU0348827113.USD","HK0000500386.USD","80883","LU0456827905.SGD","LU1868837565.USD","BK1536","LU1226287875.USD","600938","LU0456854461.SGD","LU1497734951.SGD","01787","LU0164880469.USD","LU2097828557.USD","HK0000320264.USD","LU0370786039.SGD","IE00BZ08YR35.GBP","LU2213484517.USD","LU0823041008.USD","LU2097828631.EUR","LU2097828714.EUR","LU0918141705.HKD","LU0320764599.SGD","LU2257852520.SGD","LU0164872284.USD","IE0034224299.USD","BK1502","LU1634259391.SGD","LU0052750758.USD","LU0211977185.USD","LU0561508036.HKD","LU0051755006.USD","LU0823039010.USD","LU1807302812.USD","LU1226287529.USD","LU0441854154.USD","BK1506","LU2097828805.USD","81810","BK1618","LU0266512473.USD","LU2039709279.SGD","SGXZ86797644.SGD","LU0823397103.USD","LU0149721374.USD","LU1868838027.USD","LU1813983027.USD","LU1880383366.USD","HK0000252160.HKD","LU0328353924.USD","LU0708995583.HKD","LU0572944931.SGD","LU0531971595.HKD","LU0469268626.HKD","LU0054450605.USD","LU1303224171.USD","LU2152927971.USD","LU1188198961.HKD","LU0140636845.USD","LU1008478684.HKD","LU1226288253.USD","LU1808992512.USD","LU0214875030.USD","LU1951186391.HKD","LU0359202008.SGD","LU1981816686.USD","LU0531970944.HKD","LU1720050803.USD","600547","BK1505","LU0501845795.SGD","LU0244354667.USD","LU1328277881.USD","BK1191","LU1497733557.USD","LU0048580855.USD","LU1719994722.HKD","LU0823038988.USD","LU0084288322.USD","LU0348735423.USD","IE00BZ08YS42.EUR","LU0737861772.HKD","LU0359201612.USD","BK1152","HK0000306685.HKD","HK0000320223.HKD","SGXZ62798434.SGD","LU0886674414.USD","LU0979878070.USD","LU1497733631.SGD","LU0823426480.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2607016519","title":"北水动向|北水成交净买入32.22亿 石药集团(01093)宣布重磅BD交易 北水抢筹超9亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607016519","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607016519?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:54","pubTimestamp":1769766844,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1月30日港股市场，北水成交净买入32.22亿港元，其中港股通(沪)成交净买入20.39亿港元，港股通(深)成交净买入11.83亿港元。北水净买入最多的个股是石药集团、小米集团-W、盈富基金。港股通(沪)活跃成交股港股通(深)活跃成交股石药集团获净买入9.36亿港元。盈富基金获净买入5.89亿港元。长飞光纤光缆获净买入2.41亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1880383440.USD","LU1023057109.AUD","BK1592","LU2125910500.SGD","LU1242518857.USD","LU0708995153.HKD","LU0880133367.SGD","LU0106959298.USD","LU0197773160.USD","LU1224709979.USD","LU0708995583.HKD","BK1501","SG9999002828.SGD","LU0197773673.USD","LU0417516902.SGD","LU1303224171.USD","LU0588545904.SGD","LU0214875030.USD","IE00B0169N27.USD","LU2399975544.HKD","LU1051769294.HKD","LU0640798160.USD","LU1481107354.HKD","LU2045819591.USD","LU0819123356.HKD","LU0320764599.SGD","LU2097828474.EUR","LU1810669033.SGD","LU0791591158.USD","LU0348825331.USD","IE00BMPRXN33.USD","SG9999001689.USD","LU1993786604.SGD","LU0463099449.HKD","BK1615","LU0211977185.USD","LU1807302812.USD","LU1282649141.HKD","BK1249","LU2293587155.HKD","BK1142","LU0675040207.SGD","LU0651946864.USD","IE00BZ08YS42.EUR","LU1769817096.USD","LU0823413660.USD","LU0328353924.USD","LU0593848301.USD","LU0502904849.HKD","LU0261947096.USD","LU0540923850.HKD","SG9999001051.SGD","LU1226287529.USD","LU0149534421.HKD","LU0164872284.USD","LU0130103400.USD","LU0828237940.HKD","LU0047713382.USD","IE0008369823.USD","IE00BZ08YR35.GBP","LU0642271901.SGD","BK1608","BK1610","LU0572940350.SGD","LU0700851271.USD","LU2125910849.SGD","LU0823426308.USD","LU0049853897.USD","LU0345776255.USD","SG9999002562.SGD","LU1323998911.USD","LU0128522744.USD","LU0605514214.HKD","LU1328615791.USD","SG9999000459.SGD","LU2097829019.USD","IE0032431581.USD","LU0345780521.USD","LU0149721374.USD","BK1198","LU0052750758.USD","LU0327786744.USD","IE00B3M56506.USD","IE0003895053.USD","LU0784639295.USD","LU0886674414.USD","LU0456846285.SGD","LU1115378108.SGD","LU0417516571.SGD","LU1328277881.USD","LU1548497426.USD","LU0210526637.USD","LU1282649067.USD","LU0106252389.USD","BK1618","LU0455707207.USD","LU0823040885.USD","LU0011963245.USD","LU0231483743.USD","LU0608807433.USD","LU3063872942.SGD","LU0348805143.USD","LU0348788117.USD","LU0329678170.USD","LU0054237671.USD","LU0039217434.USD","LU0456827905.SGD","LU0737861699.HKD","LU0370786039.SGD","LU1808992512.USD","LU0164880469.USD","LU0577902371.SGD","LU1224444064.USD","LU1211504680.USD","LU0594300419.USD","HBBD.SI","HK0000165453.HKD","LU2357305700.SGD","LU0588545490.SGD","LU0173614495.USD","LU0348784397.USD","LU1152091168.USD","LU2097828557.USD","LU0431992006.USD","LU0359201612.USD","IE00B031HY20.USD","LU1008478684.HKD","LU0561508036.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU0196878994.USD","LU2097828631.EUR","LU1868837565.USD","LU0228367735.SGD","LU0348783233.USD","LU1044876610.USD","LU0543330483.HKD","LU0307460666.USD","LU0314109678.HKD","LU0541501648.USD","SG9999001903.USD","LU0359202008.SGD","LU1956131251.USD","LU0449509016.USD","BK1517","LU0477156797.USD","LU1515016050.SGD","LU1770034418.SGD","LU0979878070.USD","LU0630378692.HKD","LU0862451837.USD","LU2476274308.USD","IE0034224299.USD","IE00BPRC5H50.USD","LU1251922891.USD","LU0823413587.USD","LU1316542783.SGD","LU2097828714.EUR","BK1515","LU1688375341.USD","BK1588","LU0029875118.USD","LU0072913022.USD","LU1568876335.HKD","LU0823041008.USD","LU1282651048.USD","LU0890818403.SGD","BK1591","LU0164865239.USD","LU0169518387.USD","LU1720050803.USD","LU1282651121.HKD","LU1813983027.USD","IE00BZ08YT58.USD","LU0823426480.USD","LU0315178854.USD","IE00B0JY6N72.USD","LU0577902611.USD","LU0348735423.USD","89988","LU1366334578.USD","LU0831093199.SGD","LU0531971595.HKD","LU0823039010.USD","LU0348827113.USD","LU2152927971.USD","LU0320764755.SGD","LU0140636845.USD","SG9999001093.SGD","LU1868838027.USD","LU0577902538.SGD","LU1831875114.USD","LU1048588211.SGD","LU0865486749.SGD","LU2097828805.USD","LU1770036033.HKD","BK1505","LU0235996351.USD","LU0469268626.HKD","LU0396098781.USD","LU0449515922.USD","LU0499858602.USD","LU0315179316.USD","HK0000320264.USD","LU1504937902.USD","SG9999006597.SGD","SG9999014674.SGD","LU0067412154.USD","LU0210527791.USD","LU0589944569.HKD","LU0651947912.USD","BK1575","LU0132412106.USD","LU0345780281.USD","LU0143863198.USD","LU0048388663.USD","LU1769817179.HKD","LU0181495838.USD","LU0898667661.SGD","HK0000306701.USD","LU0287142896.SGD","LU0737861772.HKD","LU0117844026.USD","LU1981816686.USD","LU0672654166.SGD","LU0261950983.USD","LU1439103000.SGD","HK0000320223.HKD","LU0594300179.USD","LU0320764243.SGD","LU0106259558.USD","LU1568876251.USD","LU0650527681.SGD","LU0266512473.USD","BK1544","LU0831103253.SGD","LU1242518931.SGD","LU0871576103.HKD","LU0048597586.USD","01093","LU0611395673.USD","LU0873338254.USD","SG9999000327.SGD","HK0000306685.HKD","LU1196710864.SGD","LU0348783662.USD","LU0229945570.USD","LU0072462343.USD","LU1188198961.HKD","LU1051768304.USD","LU0096374516.USD","LU2039709279.SGD","LU0293314216.USD","LU0577902454.USD","LU0607220059.USD","LU1720051108.HKD","LU2778985437.USD","LU0819121731.USD","LU0266512127.USD","BK1502","LU0456854461.SGD","LU1226288170.HKD","LU0384037296.USD","LU1226287792.SGD","LU0264606111.USD","IE00B543WZ88.USD","LU0029874905.USD","LU1366334651.USD","LU0051755006.USD","IE0008368742.USD","LU0359201885.HKD","SG9999004220.SGD","SG9999002463.SGD","LU0572939691.SGD","LU1880398554.USD","LU1048596156.SGD","LU0329678337.USD","LU1960683339.HKD","LU1282649810.SGD","LU0588546209.SGD","LU0117841782.USD","LU1152091754.HKD","LU0048580855.USD","LU0577902298.EUR","LU2449936058.SGD","LU0488056044.USD","LU0259732245.USD","LU0163747925.USD","LU0128522157.USD","LU1226287875.USD","LU1044874839.SGD","LU1720051017.SGD","LU0054450605.USD","LU1961090484.USD","BK1586","LU1201861165.SGD","IE00BMPRXR70.SGD","LU0648948544.HKD","LU0516422440.USD","LU0516423091.SGD","LU0499858438.USD","BK1521","LU2488822045.USD","LU0588545730.USD","LU2242644610.SGD","LU1880383366.USD","LU0130518102.USD","LU0572944931.SGD","LU0084288322.USD","LU0541502299.USD","LU0043850808.USD","SG9999001226.SGD","LU0762540952.USD","SGXZ90724238.SGD","LU2257852520.SGD","LU0862451753.SGD","LU0516422366.SGD","LU0823397103.USD","LU0821914370.USD","LU1226288253.USD","LU0823397285.USD","BK1191","LU0516423174.USD","LU0228659784.USD","LU0630378429.USD","LU0143863784.USD","LU0608807946.USD","LU0634319403.HKD","LU1794554557.SGD","LU0762542818.HKD","LU0061477393.USD","LU0856984785.SGD","LU1642822792.SGD","LU0501845795.SGD","LU0516422952.EUR","LU0648000940.SGD","LU0823038988.USD","LU0251144936.SGD","LU0244354667.USD","LU0543330566.HKD","LU0791590937.USD","LU1719994722.HKD","LU0127658192.USD","SG9999006514.SGD","LU0254981946.USD","LU2087589342.USD","LU1048484197.HKD","HSI","LU2476274720.SGD","BK1584","LU0165289439.USD","IE0008368304.USD","LU1044875133.USD","ALBmain","LU1655091459.SGD","LU0345775950.USD","LU0441854154.USD","LU1880398471.USD","LU0531970944.HKD","LU0762541174.USD","LU0868486357.SGD","LU0417516738.SGD","BK1594","LU0326950275.SGD","LU0828237510.HKD"],"gpt_icon":1},{"id":"1156105410","title":"港股期权｜权重科技股承压，阿里、腾讯期权布局显分歧；石药集团暴跌后认购期权放量","url":"https://stock-news.laohu8.com/highlight/detail?id=1156105410","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156105410?lang=zh_cn&edition=full","pubTime":"2026-01-30 12:28","pubTimestamp":1769747284,"startTime":"0","endTime":"0","summary":"截止午间收盘，港股期权半日成交逾61万张，其中，阿里巴巴成交量居首，期权成交近12万张；腾讯控股名列次席，期权成交超8.4万张；石药集团位居第三，期权成交超3.2万张。石药集团股价暴跌逾12%，此前该公司宣布与阿斯利康签订多肽药大单，潜在交易总额最高达185亿美元。期权方面，石药集团期权成交量超3.2万张，其中于2月26日到期行使价11港元的认购期权成交居前，成交近4500张。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00700","01093","09988"],"gpt_icon":0},{"id":"1143277662","title":"异动解读 | 石药集团盘中大跌11.41%，与阿斯利康达成185亿美元大单后股价高开低走","url":"https://stock-news.laohu8.com/highlight/detail?id=1143277662","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143277662?lang=zh_cn&edition=full","pubTime":"2026-01-30 10:18","pubTimestamp":1769739537,"startTime":"0","endTime":"0","summary":"石药集团今日盘中股价大幅下挫，跌幅一度超过11%，引起了市场的广泛关注。消息面上，石药集团早间宣布与全球生物制药巨头阿斯利康达成一项战略研发合作与授权协议，共同开发创新长效多肽药物。根据协议，石药集团将获得12亿美元的预付款，并有权获得最高35亿美元的研发里程碑付款和最高138亿美元的销售里程碑付款，潜在交易总额最高可达185亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01093"],"gpt_icon":0},{"id":"2607905074","title":"石药集团(01093)与阿斯利康就创新长效多肽药物开发签订战略合作与授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2607905074","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607905074?lang=zh_cn&edition=full","pubTime":"2026-01-30 08:11","pubTimestamp":1769731893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团已与全球生物制药领导者阿斯利康签订战略研发合作与授权协议，以利用集团专有的缓释给药技术平台及多肽药物AI发现平台，开发创新长效多肽药物。同时，集团的多肽药物AI发现平台可以针对药物靶点快速设计及筛选候选分子，并可在药效、选择性与信号偏向性等维度进行系统优化。根据该协议的条款，集团将与阿斯利康在创新多肽分子的发现和长效递送产品的开发方面开展全面战略合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","LU0326950275.SGD","AZN","LU1226288170.HKD","LU1813983027.USD","LU0314109678.HKD","LU0067412154.USD","LU1226287875.USD","LU2462157665.USD","SG9999004220.SGD","LU1328277881.USD","LU1960683339.HKD","01093","LU0140636845.USD","IE00B543WZ88.USD","LU1226288253.USD","LU2456880835.USD","LU1993786604.SGD","LU2236285917.USD","BK4585","BK4588","BK1191","IE00BZ08YR35.GBP","LU1226287792.SGD","LU2417539215.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","BK4007","LU1152091168.USD","HK0000165453.HKD","LU1226287529.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1807302812.USD","LU1829250122.USD","LU0889565916.HKD","BK1521","IE0008368742.USD","LU0320765992.SGD","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0880133367.SGD","LU0109394709.USD","LU0072913022.USD","LU1008478684.HKD","LU0501845795.SGD","LU1152091754.HKD","IE0008369823.USD","LU0315179316.USD","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":0.079},{"period":"3month","weight":0.2449},{"period":"6month","weight":-0.0765},{"period":"1year","weight":1.1098},{"period":"ytd","weight":0.0854}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0317},{"period":"6month","weight":0.0749},{"period":"1year","weight":0.3239},{"period":"ytd","weight":0.0447}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品（包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片）、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.71875,"avgChangeRate":0.092246},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}